Invesco Bloomberg Analyst Rating Improvers ETF (NYSEARCA:UPGD – Get Free Report) was the target of a large decrease in short interest in July. As of July 31st, there was short interest totaling 400 shares, a decrease of 49.4% from the July 15th total of 790 shares. Based on an average daily trading volume, of 1,252 shares, the short-interest ratio is presently 0.3 days. Approximately 0.0% of the shares of the stock are sold short.
Invesco Bloomberg Analyst Rating Improvers ETF Stock Down 0.2%
NYSEARCA:UPGD traded down $0.18 on Friday, reaching $84.46. 531 shares of the company’s stock traded hands, compared to its average volume of 2,423. The stock has a 50-day simple moving average of $82.24 and a 200-day simple moving average of $78.87. Invesco Bloomberg Analyst Rating Improvers ETF has a 12 month low of $70.85 and a 12 month high of $84.73. The firm has a market cap of $121.62 million, a PE ratio of 20.47 and a beta of 0.93.
Institutional Trading of Invesco Bloomberg Analyst Rating Improvers ETF
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Northwestern Mutual Wealth Management Co. boosted its stake in Invesco Bloomberg Analyst Rating Improvers ETF by 52,865.8% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 768,004 shares of the company’s stock worth $56,825,000 after purchasing an additional 766,554 shares during the period. Aspire Growth Partners LLC raised its position in shares of Invesco Bloomberg Analyst Rating Improvers ETF by 1.7% during the fourth quarter. Aspire Growth Partners LLC now owns 10,518 shares of the company’s stock valued at $778,000 after buying an additional 178 shares during the last quarter. Tower Research Capital LLC TRC raised its position in shares of Invesco Bloomberg Analyst Rating Improvers ETF by 85.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 26,578 shares of the company’s stock valued at $1,966,000 after buying an additional 12,267 shares during the last quarter. Stifel Financial Corp purchased a new position in shares of Invesco Bloomberg Analyst Rating Improvers ETF in the fourth quarter worth $251,000. Finally, HRT Financial LP lifted its holdings in shares of Invesco Bloomberg Analyst Rating Improvers ETF by 51.6% in the fourth quarter. HRT Financial LP now owns 9,026 shares of the company’s stock worth $667,000 after buying an additional 3,073 shares in the last quarter.
About Invesco Bloomberg Analyst Rating Improvers ETF
The Invesco Bloomberg Analyst Rating Improvers ETF (UPGD) is an exchange-traded fund that is based on the Bloomberg ANR Improvers index. The fund tracks an equal-weighted index of large-and mid-cap US stocks that are identified to have the most improved consensus ratings based on analyst recommendations. UPGD was launched on May 19, 2006 and is issued by Invesco.
See Also
- Five stocks we like better than Invesco Bloomberg Analyst Rating Improvers ETF
- The Metals Company’s Big Bet Now Comes Down to a License
- OneSpaWorld Keeps Turning Cruise Demand Into Record Earnings
- Meta and Tesla Are Rebounding From Oversold Levels—Now What?
- AMG’s Alternatives Boom Powers Record Growth
Receive News & Ratings for Invesco Bloomberg Analyst Rating Improvers ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Bloomberg Analyst Rating Improvers ETF and related companies with MarketBeat.com's FREE daily email newsletter.
